drugset / Trial / NCT02957097

Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures

NCT02957097

Phase 4 Withdrawn Massachusetts General Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the effectiveness of pre-operative administration of gabapentin 900 mg in management of acute post-operative pain in patients undergoing oral and maxillofacial surgical procedures.

Timeline

Start
2019-09
Primary completion
2021-06
Completion
2021-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 900 mg Oral